top of page
Search

When the Test Does Not Know About Your Prescription: Drug Testing and Medical Cannabis at Work

Comic book style illustration of a nervous young male plumber in a hi-vis vest sitting in a workplace drug testing room, looking anxious while waiting for the results of a mandatory drug test. Prescription medication bottles and work tools are visible nearby. Text reads “When the Test Doesn’t About Your Prescription: Drug Testing and Medical Cannabis at Work”. BlindSpot Solutions eye logo visible.

This scenario comes from the BlindSpot Accessibility Playbook. It is one of many situations where a workplace policy designed to promote safety creates an unintended barrier for employees with lawful medical needs.


The drug test is standard. The employee is required to attend. They have a valid prescription for medicinal cannabis, prescribed by their doctor to manage a mental health condition. They take it at night, as directed. The metabolites remain detectable in urine for days or weeks after use, long after any impairing effect has passed.


The test returns positive. Drug testing and medical cannabis at work immediately collide. The employer is looking at a positive result. The employee is looking at having to explain a medical condition they had not disclosed, in a context they had not chosen, under conditions that feel more like an accusation than an enquiry.


They did nothing wrong. The policy was not written with them in mind.



Drug Testing and Medical Cannabis at Work: The Policy Gap


The number of Australians prescribed medicinal cannabis has grown significantly since legalisation. Prescriptions are issued for conditions including anxiety, PTSD, chronic pain, insomnia, and other mental health conditions. These are often the same conditions that workplace stress can exacerbate.


Standard urine testing detects the presence of THC metabolites, not impairment. A positive result indicates prior use, not current impairment. Treating prior lawful medical use as equivalent to illicit drug use conflates two very different things, and may constitute indirect discrimination against employees with a disability.


The employee is not impaired. They are prescribed.



What a Policy That Accounts for Prescriptions Looks Like


Drug testing policies should include a clear, confidential pre-declaration process that allows employees to disclose prescribed medications before testing. The policy should explicitly address medicinal cannabis, acknowledging that detection does not equal impairment and that lawful prescription use is handled separately from illicit use.


Where safety-critical roles require managing impairment risk, the policy should address that specifically, with reference to the particular role rather than applying a blanket prohibition that treats all positive results the same regardless of cause.


“If you are taking a prescribed medication that may affect your test result, you can declare this confidentially before testing. Lawful prescriptions are handled through a separate, private process.”


Drug testing and medical cannabis at work are a growing intersection. Policies that have not been updated to address it are already behind the reality of the workforce they cover.



Want to Go Deeper?


Scenarios like this are common, but they are often overlooked because they feel ordinary. Learning to spot them, and knowing how to respond well, is a core part of building more inclusive workplace experiences.


BlindSpot Solutions offers a range of Accessibility Awareness services designed to support this in practice, including workshops, workplace reviews, the Accessibility Awareness Playbook, and the Accessibility Awareness Learning Program.


If you would like to explore how this could apply in your organisation, you can submit an enquiry form, send an email, or browse the website to learn more.


Small Change. Big Impact


Comments

bottom of page